Expanding Immunotheapy Benefit in Metastatic RCC
Journal of Clinical Oncology (JCO) Podcast · Brian I. Rini
January 11, 20166m 33s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Discussion of a phase I trial of the checkpoint inhibitor atezolizumab in metastatic renal carcinoma.